应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CHRS Coherus Biosciences
未开盘 05-06 16:00:00 EDT
0.9299
-0.0901
-8.83%
盘后
0.9447
+0.0148
+1.59%
19:32 EDT
最高
1.02
最低
0.9174
成交量
195.62万
今开
1.01
昨收
1.02
日振幅
9.57%
总市值
1.08亿
流通市值
1.03亿
总股本
1.16亿
成交额
184.53万
换手率
1.77%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.00%
市场透视 · 05-05 15:26
Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.00%
Coherus Biosciences, Inc.盘中异动 大幅拉升5.71%
市场透视 · 05-02
Coherus Biosciences, Inc.盘中异动 大幅拉升5.71%
Coherus Biosciences, Inc.盘中异动 股价大涨5.04%
市场透视 · 04-30
Coherus Biosciences, Inc.盘中异动 股价大涨5.04%
Coherus Biosciences, Inc.盘中异动 股价大跌5.08%
市场透视 · 04-28
Coherus Biosciences, Inc.盘中异动 股价大跌5.08%
Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.41%
市场透视 · 04-24
Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.41%
Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.05%
市场透视 · 04-23
Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.05%
Coherus Biosciences, Inc.盘中异动 股价大跌5.80%报1.06美元
市场透视 · 04-21
Coherus Biosciences, Inc.盘中异动 股价大跌5.80%报1.06美元
Coherus Biosciences, Inc.盘中异动 股价大涨5.68%
市场透视 · 04-15
Coherus Biosciences, Inc.盘中异动 股价大涨5.68%
Coherus Biosciences, Inc.盘中异动 快速拉升8.69%报0.909美元
市场透视 · 04-14
Coherus Biosciences, Inc.盘中异动 快速拉升8.69%报0.909美元
Coherus BioSciences(CHRS.US):2024年Q4财报实现营收5414.4万美元,前值为9152.4万美元,预期值为4388万美元;每股收益为-0.28美元,前值为-0.62美元,预期值为-0.13美元。
金融界 · 03-10
Coherus BioSciences(CHRS.US):2024年Q4财报实现营收5414.4万美元,前值为9152.4万美元,预期值为4388万美元;每股收益为-0.28美元,前值为-0.62美元,预期值为-0.13美元。
Coherus BioSciences 2024年第四季度调整后每股亏损$(0.28),不及预期$(0.13),销售额$5414.4万超过预期$4727.0万
财报速递 · 03-10
Coherus BioSciences 2024年第四季度调整后每股亏损$(0.28),不及预期$(0.13),销售额$5414.4万超过预期$4727.0万
Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.77%
市场透视 · 03-10
Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.77%
Coherus Biosciences, Inc.盘中异动 股价大跌5.28%报0.976美元
市场透视 · 03-06
Coherus Biosciences, Inc.盘中异动 股价大跌5.28%报0.976美元
Coherus Biosciences, Inc.盘中异动 股价大涨5.47%报1.06美元
市场透视 · 03-04
Coherus Biosciences, Inc.盘中异动 股价大涨5.47%报1.06美元
Coherus Biosciences, Inc.盘中异动 大幅跳水5.41%
市场透视 · 03-03
Coherus Biosciences, Inc.盘中异动 大幅跳水5.41%
Coherus Biosciences, Inc.盘中异动 快速拉升5.09%
市场透视 · 02-28
Coherus Biosciences, Inc.盘中异动 快速拉升5.09%
Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.14%
市场透视 · 02-24
Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.14%
Coherus Biosciences, Inc.盘中异动 早盘急速跳水5.36%
市场透视 · 02-19
Coherus Biosciences, Inc.盘中异动 早盘急速跳水5.36%
Coherus Biosciences, Inc.盘中异动 大幅下跌5.00%
市场透视 · 02-18
Coherus Biosciences, Inc.盘中异动 大幅下跌5.00%
Coherus Biosciences, Inc.盘中异动 下午盘大幅下挫5.13%报1.11美元
市场透视 · 02-11
Coherus Biosciences, Inc.盘中异动 下午盘大幅下挫5.13%报1.11美元
加载更多
公司概况
公司名称:
Coherus Biosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Coherus Biosciences, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司,专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权,其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。
发行价格:
--
{"stockData":{"symbol":"CHRS","market":"US","secType":"STK","nameCN":"Coherus Biosciences","latestPrice":0.9299,"timestamp":1746561600000,"preClose":1.02,"halted":0,"volume":1956187,"hourTrading":{"tag":"盘后","latestPrice":0.9447,"preClose":0.9299,"latestTime":"19:32 EDT","volume":8068,"amount":7539.139,"timestamp":1746574328063},"delay":0,"floatShares":110604106,"shares":115896849,"eps":0.248853,"marketStatus":"未开盘","change":-0.0901,"latestTime":"05-06 16:00:00 EDT","open":1.01,"high":1.015,"low":0.9174,"amount":1845319.59316638,"amplitude":0.095686,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.248853,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1415250000000,"exchange":"NASDAQ","adjPreClose":1.02,"preHourTrading":{"tag":"盘前","latestPrice":1.0101,"preClose":1.02,"latestTime":"08:13 EDT","volume":650,"amount":656.565,"timestamp":1746533614372},"postHourTrading":{"tag":"盘后","latestPrice":0.9447,"preClose":0.9299,"latestTime":"19:32 EDT","volume":8068,"amount":7539.139,"timestamp":1746574328063},"volumeRatio":1.405182,"impliedVol":0.62,"impliedVolPercentile":0.18},"requestUrl":"/m/hq/s/CHRS","defaultTab":"news","newsList":[{"id":"2533534333","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533534333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533534333?lang=zh_cn&edition=full","pubTime":"2025-05-05 23:26","pubTimestamp":1746458794,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日23时26分,Coherus Biosciences, Inc.股票出现波动,股价大幅跳水5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家处于商业化阶段的生物制药公司,专注于癌症治疗的创新免疫疗法的研究、开发和商业化。Coherus 正在开发一条创新的免疫肿瘤学研发管线,其中包括多种候选抗体免疫疗法,旨在增强先天和适应性免疫反应,以实现强大的抗肿瘤免疫反应,并改善癌症患者的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505232635a472ed55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505232635a472ed55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2532964844","title":"Coherus Biosciences, Inc.盘中异动 大幅拉升5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532964844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532964844?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:32","pubTimestamp":1746192747,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时32分,Coherus Biosciences, Inc.股票出现异动,股价大幅上涨5.71%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.33%。其相关个股中,Polyrizon Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Adaptive Biotechnologies Corporation涨幅较大,Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为204.67%、150.99%、58.11%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.、Adaptive Biotechnologies Corporation,振幅分别为67.34%、34.37%、18.34%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家处于商业化阶段的生物制药公司,专注于癌症治疗的创新免疫疗法的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221322794eac261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050221322794eac261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2532095644","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532095644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532095644?lang=zh_cn&edition=full","pubTime":"2025-05-01 03:51","pubTimestamp":1746042662,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日03时51分,Coherus Biosciences, Inc.股票出现异动,股价大幅上涨5.04%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.63%。其相关个股中,Regulus Therapeutics Inc.、Nutriband Inc C/Wts 、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃,换手率分别为166.19%、51.40%、40.85%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Abeona Therapeutics Inc.,振幅分别为64.00%、42.50%、37.52%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家处于商业化阶段的生物制药公司,专注于癌症治疗的创新免疫疗法的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501035103a6cf395f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501035103a6cf395f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2531255811","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531255811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531255811?lang=zh_cn&edition=full","pubTime":"2025-04-29 01:34","pubTimestamp":1745861696,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日01时34分,Coherus Biosciences, Inc.股票出现波动,股价大幅下跌5.08%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Cg Oncology, Inc.、Regulus Therapeutics Inc.、Ibio, Inc.涨幅较大,Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Onconetix, Inc.较为活跃,换手率分别为2526.80%、501.37%、118.31%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Relmada Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.,振幅分别为60.43%、58.98%、54.78%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家处于商业化阶段的生物制药公司,专注于癌症治疗的创新免疫疗法的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429013457aa2c7d61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429013457aa2c7d61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4139","BK4535"],"gpt_icon":0},{"id":"2529347119","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529347119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529347119?lang=zh_cn&edition=full","pubTime":"2025-04-24 22:16","pubTimestamp":1745504182,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日22时16分,Coherus Biosciences, Inc.股票出现波动,股价快速下跌5.41%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家处于商业化阶段的生物制药公司,专注于癌症治疗的创新免疫疗法的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424221622a6c6b9f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424221622a6c6b9f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2529068242","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529068242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529068242?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:47","pubTimestamp":1745416052,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时47分,Coherus Biosciences, Inc.股票出现异动,股价大幅拉升5.05%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.92%。其相关个股中,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Instil Bio, Inc.涨幅较大,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Ocean Biomedical, Inc.较为活跃,换手率分别为4459.11%、47.51%、27.40%,振幅较大的相关个股有Silexion Therapeutics Corp、Ensysce Biosciences, Inc.、Ocean Biomedical, Inc.,振幅分别为54.21%、52.94%、33.25%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家处于商业化阶段的生物制药公司,专注于癌症治疗的创新免疫疗法的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321473294dfac83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321473294dfac83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2529580742","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.80%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529580742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529580742?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:03","pubTimestamp":1745244191,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时03分,Coherus Biosciences, Inc.股票出现波动,股价大幅下跌5.80%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家处于商业化阶段的生物制药公司,专注于癌症治疗的创新免疫疗法的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220311973f7993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220311973f7993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2527329417","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527329417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527329417?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:36","pubTimestamp":1744724190,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时36分,Coherus Biosciences, Inc.股票出现异动,股价大幅拉升5.68%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213630aa2c6fa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213630aa2c6fa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2527164988","title":"Coherus Biosciences, Inc.盘中异动 快速拉升8.69%报0.909美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527164988?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:31","pubTimestamp":1744637482,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分,Coherus Biosciences, Inc.股票出现波动,股价大幅上涨8.69%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大,Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃,换手率分别为273.34%、128.22%、86.14%,振幅较大的相关个股有Armata Pharmaceuticals, Inc.、Silence Therapeutics Plc、Proqr Therapeutics N.V.,振幅分别为12.50%、10.98%、9.32%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213122aa2c6e01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213122aa2c6e01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2518783267","title":"Coherus BioSciences(CHRS.US):2024年Q4财报实现营收5414.4万美元,前值为9152.4万美元,预期值为4388万美元;每股收益为-0.28美元,前值为-0.62美元,预期值为-0.13美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518783267","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518783267?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:31","pubTimestamp":1741638703,"startTime":"0","endTime":"0","summary":"Coherus BioSciences(CHRS.US):2024年Q4财报实现营收5414.4万美元,前值为9152.4万美元,预期值为4388万美元;每股收益为-0.28美元,前值为-0.62美元,预期值为-0.13美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11043148642742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CHRS"],"gpt_icon":0},{"id":"1109189574","title":"Coherus BioSciences 2024年第四季度调整后每股亏损$(0.28),不及预期$(0.13),销售额$5414.4万超过预期$4727.0万","url":"https://stock-news.laohu8.com/highlight/detail?id=1109189574","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109189574?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:18","pubTimestamp":1741637918,"startTime":"0","endTime":"0","summary":"Coherus BioSciences 报告季度每股亏损$,低于分析师一致预期的$,减少了115.38%。与去年同期每股亏损$相比,这是一个54.84%的改善。公司报告季度销售额为$5414.4万,超过分析师一致预期的$4727.0万,高出14.54%。以上内容来自Benzinga Earnings专栏,原文如下:Coherus BioSciences reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 115.38 percent. This is a 54.84 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $54.144 million which beat the analyst consensus estimate of $47.270 million b","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Coherus BioSciences 2024年第四季度调整后每股亏损$(0.28),不及预期$(0.13),销售额$5414.4万超过预期$4727.0万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRS"],"gpt_icon":0},{"id":"2518227963","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227963?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:43","pubTimestamp":1741614197,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时43分,Coherus Biosciences, Inc.股票出现异动,股价急速拉升5.77%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。其相关个股中,Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2346.37%、549.18%、83.46%,振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.,振幅分别为40.24%、28.59%、25.35%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021431798a29fe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021431798a29fe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2517319875","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.28%报0.976美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517319875?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:20","pubTimestamp":1741281608,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时20分,Coherus Biosciences, Inc.股票出现波动,股价急速下跌5.28%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.75%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012008989ed2d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012008989ed2d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2517698570","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.47%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517698570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517698570?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:03","pubTimestamp":1741118611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时03分,Coherus Biosciences, Inc.股票出现波动,股价快速上涨5.47%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040331989bf850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040331989bf850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2516654568","title":"Coherus Biosciences, Inc.盘中异动 大幅跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654568?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:10","pubTimestamp":1741025425,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时10分,Coherus Biosciences, Inc.股票出现波动,股价急速跳水5.41%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021026a25d7f84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021026a25d7f84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2514750043","title":"Coherus Biosciences, Inc.盘中异动 快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514750043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514750043?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:32","pubTimestamp":1740756734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时32分,Coherus Biosciences, Inc.股票出现波动,股价快速拉升5.09%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233214989687b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233214989687b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2514987776","title":"Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514987776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514987776?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:36","pubTimestamp":1740414967,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时36分,Coherus Biosciences, Inc.股票出现波动,股价急速上涨5.14%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药,UDENYCA,并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003608962eb475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003608962eb475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2512810254","title":"Coherus Biosciences, Inc.盘中异动 早盘急速跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512810254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512810254?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:05","pubTimestamp":1739981106,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时05分,Coherus Biosciences, Inc.股票出现异动,股价大幅下挫5.36%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000506a24c0d6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000506a24c0d6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2512931101","title":"Coherus Biosciences, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512931101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512931101?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:10","pubTimestamp":1739902251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时10分,Coherus Biosciences, Inc.股票出现异动,股价大幅下挫5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.58%。其相关个股中,Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大,Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃,换手率分别为652.29%、197.44%、164.02%,振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.,振幅分别为148.75%、92.00%、79.17%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021051a24adaa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021051a24adaa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2510532973","title":"Coherus Biosciences, Inc.盘中异动 下午盘大幅下挫5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510532973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510532973?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:32","pubTimestamp":1739298734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时32分,Coherus Biosciences, Inc.股票出现异动,股价急速下挫5.13%。Coherus Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.79%。其相关个股中,Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为3092.34%、1432.04%、482.65%,振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为143.33%、72.23%、58.60%。Coherus Biosciences, Inc.公司简介:Coherus BioSciences Inc 是一家商业阶段的生物制药公司,利用 FDA 批准的多元化疗法组合产生的现金,资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023214a2422ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023214a2422ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coherus.com","stockEarnings":[{"period":"1week","weight":-0.0697},{"period":"1month","weight":0.1894},{"period":"3month","weight":-0.2251},{"period":"6month","weight":0.134},{"period":"1year","weight":-0.5811},{"period":"ytd","weight":-0.3262}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.1059},{"period":"3month","weight":-0.0752},{"period":"6month","weight":-0.0618},{"period":"1year","weight":0.0818},{"period":"ytd","weight":-0.0465}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coherus Biosciences, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司,专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权,其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.000743},{"month":2,"riseRate":0.454545,"avgChangeRate":0.005379},{"month":3,"riseRate":0.454545,"avgChangeRate":0.004197},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.031006},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.014067},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013481},{"month":7,"riseRate":0.5,"avgChangeRate":0.086566},{"month":8,"riseRate":0.8,"avgChangeRate":0.10749},{"month":9,"riseRate":0.1,"avgChangeRate":-0.143671},{"month":10,"riseRate":0.3,"avgChangeRate":-0.071307},{"month":11,"riseRate":0.5,"avgChangeRate":0.013066},{"month":12,"riseRate":0.545455,"avgChangeRate":0.040313}],"exchange":"NASDAQ","name":"Coherus Biosciences","nameEN":"Coherus BioSciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.3","shortVersion":"4.33.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Coherus Biosciences,CHRS,Coherus Biosciences股票,Coherus Biosciences股票老虎,Coherus Biosciences股票老虎国际,Coherus Biosciences行情,Coherus Biosciences股票行情,Coherus Biosciences股价,Coherus Biosciences股市,Coherus Biosciences股票价格,Coherus Biosciences股票交易,Coherus Biosciences股票购买,Coherus Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}